NASDAQ:QDEL - Quidel Stock Price, Forecast & News

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Quidel Co. (NASDAQ:QDEL) announced its quarterly earnings results on Wednesday, October, 30th. The company reported $0.70 EPS for the quarter, beating analysts' consensus estimates of $0.64 by $0.06. The company earned $126.50 million during the quarter, compared to analysts' expectations of $125.52 million. Quidel had a return on equity of 22.48% and a net margin of 14.51%. Quidel's revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.59 EPS. View Quidel's Earnings History.

Quidel is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Quidel.

Quidel issued an update on its fourth quarter 2019 After-Hours earnings guidance on Thursday, January, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $151-152 million, compared to the consensus revenue estimate of $139.17 million.

4 equities research analysts have issued 1 year price targets for Quidel's stock. Their forecasts range from $74.00 to $77.00. On average, they anticipate Quidel's stock price to reach $75.25 in the next year. This suggests that the stock has a possible downside of 4.2%. View Analyst Price Targets for Quidel.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Quidel.

News articles about QDEL stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Quidel earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Quidel.

Quidel saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 2,340,000 shares, an increase of 7.8% from the November 28th total of 2,170,000 shares. Based on an average daily trading volume, of 170,500 shares, the days-to-cover ratio is currently 13.7 days. Currently, 6.4% of the shares of the stock are sold short. View Quidel's Current Options Chain.

Some companies that are related to Quidel include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Antares Pharma (ATRS), Cerus (CERS), Anika Therapeutics (ANIK), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include Netflix (NFLX), Adobe (ADBE), Intel (INTC), NVIDIA (NVDA), Alibaba Group (BABA), Mastercard (MA), Advanced Micro Devices (AMD), Energy Transfer LP Unit (ET), Visa (V) and Cisco Systems (CSCO).

Quidel's stock is owned by a variety of of institutional and retail investors. Top institutional investors include AMI Asset Management Corp (0.27%), Zurcher Kantonalbank Zurich Cantonalbank (0.01%), McAdam LLC (0.01%), Strs Ohio (0.00%), Exchange Traded Concepts LLC (0.00%) and Nisa Investment Advisors LLC (0.00%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Institutional Ownership Trends for Quidel.

QDEL stock was sold by a variety of institutional investors in the last quarter, including AMI Asset Management Corp. Company insiders that have sold Quidel company stock in the last year include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Insider Buying and Selling for Quidel.

QDEL stock was bought by a variety of institutional investors in the last quarter, including McAdam LLC, Exchange Traded Concepts LLC, Zurcher Kantonalbank Zurich Cantonalbank , Strs Ohio and Nisa Investment Advisors LLC. View Insider Buying and Selling for Quidel.

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of QDEL stock can currently be purchased for approximately $78.53.

Quidel has a market capitalization of $3.27 billion and generates $522.28 million in revenue each year. The company earns $74.18 million in net income (profit) each year or $2.82 on an earnings per share basis. Quidel employs 1,224 workers across the globe.View Additional Information About Quidel.

The official website for Quidel is http://www.quidel.com/.

Quidel's mailing address is 12544 HIGH BLUFF DRIVE SUITE 200, SAN DIEGO CA, 92130. The company can be reached via phone at 858-552-1100 or via email at [email protected]